Vulnerable plaque PCI after PREVENT

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/47/51/05/475105a5-3620-0e30-29c8-d1e9b61ed7b7/mza_6886755722591689747.jpeg/600x600bb.jpg

PCR Perspectives

PCR

33 episodes

4 days ago

Stay at the forefront of interventions for valvular heart disease, coronary, and structural interventions with expert insights and perspectives. These interviews explore the techniques, tools, and key topics shaping the ever-evolving field of interventional cardiology

Hosted on Acast. See acast.com/privacy for more information.

All content for PCR Perspectives is the property of PCR and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Hosted on Acast. See acast.com/privacy for more information.

Medicine

Education,

Health & Fitness

https://assets.pippa.io/shows/67bc9816b63437eabc3c8036/1740414554289-af656d96-6b01-43c9-9fcb-9dabd8a345f4.jpeg

Vulnerable plaque PCI after PREVENT

PCR Perspectives

4 minutes 44 seconds

2 months ago

Vulnerable plaque PCI after PREVENT

What does the PREVENT trial tell us about managing vulnerable plaques?

Recorded during #europcr 2025, this discussion features Michael Haude and Thomas Cuisset as they review key insights from this major study of over 1,600 patients with physiologically non-significant but vulnerable plaques identified by intracoronary imaging—mainly IVUS.

Patients were randomised to receive either optimal medical therapy (OMT) alone or combined with preventive PCI, and followed over several years. While the composite endpoint favored the PCI group, the benefit was driven solely by a reduction in target lesion revascularisation—without differences in death or myocardial infarction.

Should PCI be systematically performed in such cases? Tune in for a nuanced expert perspective!

Hosted on Acast. See acast.com/privacy for more information.